Global Sinusitis Treatment Market: Current Analysis and Forecast (2022-2028)

Global Sinusitis Treatment Market: Current Analysis and Forecast (2022-2028)

Sinusitis is a medical condition that causes inflammation along the sinus lining, which can cause symptoms like facial pain, sinus headaches, breathing problems, fatigue, tooth pain, and a loss of taste and smell. The growing demand for sinus treatment can be attributed to the increasing prevalence of rhinosinusitis across the globe. For instance, according to the World Allergy Organization 2021, the worldwide prevalence of chronic rhinosinusitis (CRS) ranges from about 8% in China, 8.4% in Korea, 11% in Europe, and 12% in the United States. Furthermore, the increasing investments in the research and development of novel medicines also attributes to the significant growth of the market.

The increasing demand for diagnostics is expected to drive the global sinusitis treatment market at a CAGR of 5%, during the forecast period. Factors such as rapid technological advancement and integration of information technology in healthcare are important factors responsible for the market growth of the sinusitis treatment market.

• Based on the disease, the market has been categorized into acute sinusitis, sub-acute sinusitis, and chronic sinusitis. Among them, the chronic sinusitis segment holds a considerable share of the market. The rising incidences of chronic sinusitis along with the rise in air pollution are the important factors contributing to the share of the chronic sinusitis segment. For instance, according to the National Institute of Allergy and Infectious Diseases (NIAID), an estimated 134 million Indians suffer from chronic sinusitis.
• Based on the treatment, the market has been categorized into analgesics, antihistamines, corticosteroids, antibiotics, and surgery. Among them, the antibiotics segment holds a considerable share of the market. The increasing prevalence of high effectiveness of the antibodies against them attributes to the significant share of the antibodies in the sinusitis treatment.
• For a better understanding of the market adoption of the sinusitis treatment, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated to hold a considerable market share during the forecast period. The rising number of sinusitis cases along with the presence of a large geriatric population in the region attributes to the significant share of sinusitis treatment. For instance, according to the University of Michigan Health Michigan Medicines, Chronic sinusitis affects 31 million people in the U.S. and accounts for more than 16 million outpatient visits a year.
• Some of the major players operating in the market are Olympus Corporation; Medtronic; Stryker; Cipla Inc.; Dr. Reddy’s Laboratories Ltd; Sanofi; Aurobindo Pharma; Intersect ENT, Inc.; Smith+Nephew; and Novartis AG